Thrivent Financial for Lutherans Boosts Stock Position in Cardinal Health, Inc. $CAH

Thrivent Financial for Lutherans grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 60.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 22,289 shares of the company’s stock after buying an additional 8,368 shares during the period. Thrivent Financial for Lutherans’ holdings in Cardinal Health were worth $4,586,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in CAH. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Holocene Advisors LP lifted its holdings in Cardinal Health by 141.4% in the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after purchasing an additional 1,128,358 shares in the last quarter. Barclays PLC lifted its holdings in Cardinal Health by 109.3% in the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock worth $248,658,000 after purchasing an additional 827,446 shares in the last quarter. SG Americas Securities LLC lifted its holdings in Cardinal Health by 3,829.1% in the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock worth $149,504,000 after purchasing an additional 708,995 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in Cardinal Health by 44.9% in the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after purchasing an additional 707,495 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Mizuho boosted their price target on Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a report on Friday, February 6th. Citigroup lowered their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday. Robert W. Baird set a $248.00 price target on Cardinal Health in a report on Friday, May 1st. Finally, William Blair assumed coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Price Performance

Shares of CAH opened at $200.42 on Friday. The stock has a market capitalization of $46.94 billion, a price-to-earnings ratio of 30.64, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60. The business’s 50 day simple moving average is $205.21 and its 200-day simple moving average is $208.69.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s payout ratio is currently 31.19%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.